Solara Active Pharma Sciences Ltd. - Research Center
541540 SOLARA Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 1,443.81 | 1,268.34 | 1,616.88 | 1,321.75 | 1,367.26 |
| Operating profit | 134.04 | 80.35 | 385.33 | 256.53 | 226.05 |
| Interest | 90.06 | 75.27 | 84.47 | 77.88 | 82.42 |
| Gross profit | 66.12 | 23.84 | 329.27 | 206.16 | 150.42 |
| EPS (Rs) | -6.17 | -16.27 | 61.51 | 41.88 | 24.06 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 22.14 | 18.76 | 28.41 | 27.51 | 6.79 |
| Stock adjustment | 7.05 | -258.75 | -2.15 | -32.95 | -29.28 |
| Raw material | 773.90 | 858.86 | 683.76 | 602.15 | 719.06 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 228.05 | 234.20 | 227.63 | 202.24 | 179.92 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 300.77 | 353.68 | 322.31 | 293.78 | 271.51 |
| Provisions made | - | - | - | - | - |
| Depreciation | 110.90 | 112.01 | 108.31 | 93.67 | 78.73 |
| Taxation | -22.57 | -33.10 | - | - | 2.01 |
| Net profit / loss | -22.21 | -58.56 | 220.96 | 112.49 | 62.00 |
| Extra ordinary item | - | -3.49 | - | - | -7.68 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 36.00 | 36.00 | 35.92 | 26.86 | 25.77 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 9.28 | 6.34 | 23.83 | 19.41 | 16.53 |
| GPM (%) | 4.51 | 1.85 | 20.01 | 15.28 | 10.95 |
| NPM (%) | -1.52 | -4.55 | 13.43 | 8.34 | 4.51 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis